SD Biosensor Inc
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volum… Read more
SD Biosensor Inc (137310) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, SD Biosensor Inc (137310) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.90 Billion) by net assets (₩3.07 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SD Biosensor Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how SD Biosensor Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SD Biosensor Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SD Biosensor Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Equasens S. A.
PA:EQS
|
0.191x |
|
Beijing Kingfore HV & Energy Conservation Technology Co.Ltd.
SHE:001210
|
0.077x |
|
TYC Brother Industrial Co Ltd
TW:1522
|
0.029x |
|
AerSale Corp
NASDAQ:ASLE
|
0.027x |
|
Keystone Technology Co Ltd
SHG:605588
|
0.042x |
|
Holsin Engineering Consulting
SHG:603909
|
0.014x |
|
Hwacom Systems
TWO:6163
|
0.033x |
|
UTI Inc
KQ:179900
|
-0.224x |
Annual Cash Flow Conversion Efficiency for SD Biosensor Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of SD Biosensor Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩2.93 Trillion | ₩156.53 Billion | 0.053x | +162.38% |
| 2023-12-31 | ₩2.83 Trillion | ₩-242.32 Billion | -0.086x | -128.33% |
| 2022-12-31 | ₩2.95 Trillion | ₩890.23 Billion | 0.302x | -46.10% |
| 2021-12-31 | ₩2.20 Trillion | ₩1.23 Trillion | 0.560x | -14.29% |
| 2020-12-31 | ₩757.55 Billion | ₩495.38 Billion | 0.654x | +5650.64% |
| 2019-12-31 | ₩137.91 Billion | ₩-1.62 Billion | -0.012x | -- |